Back
AdaptHealth Quote, Financials, Valuation and Earnings
Sponsored
AHCO
Sponsored
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
29
AHCO
AdaptHealth
Last Price:
9.72
Seasonality Move:
3.34%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)AdaptHealth Price Quote
$9.72
+0.18 (+1.89%)
(Updated: December 11, 2024 at 5:55 PM ET)
AdaptHealth Key Stats
Sell
29
AdaptHealth (AHCO)
is a Sell
Day range:
$9.21 - $9.67
52-week range:
$6.43 - $11.90
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.39
P/B ratio:
0.85%
Volume:
1M
Avg. volume:
1M
1-year change:
15.22%
Market cap:
$1.3B
Revenue:
$3.2B
EPS:
$-1.65
How Much Does AdaptHealth Make?
-
How Much Are AdaptHealth's Sales Annually?
AHCO Revenues are $3.2B -
How Much Profit Does AdaptHealth's Make A Year?
AHCO net income is -$678.9M
Is AdaptHealth Growing As A Company?
-
What Is AdaptHealth's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.02% -
What Is AdaptHealth's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
AdaptHealth Stock Price Performance
-
Did AdaptHealth Stock Go Up Last Month?
AdaptHealth share price went down by -5.45% last month -
Did AHCO's Share Price Rise Over The Last Year?
AHCO share price rose by 15.22% over the past 1 year
What Is AdaptHealth 52-Week High & Low?
-
What Is AdaptHealth’s 52-Week High Share Price?
AdaptHealth has traded as high as $11.90 over the past 52 weeks -
What Is AdaptHealth’s 52-Week Low Share Price?
AdaptHealth has traded as low as $6.43 over the past 52 weeks
AdaptHealth Price To Free Cash Flow
-
Is AdaptHealth Stock Overvalued?
AdaptHealth is trading at a price to free cash flow ratio of 5.60 -
Is AdaptHealth Stock Undervalued?
AdaptHealth EV to Free Cash Flow ratio is 14.05 -
What Is AdaptHealth’s Price Earnings Growth Ratio?
AHCO PEG ratio is 0.00 -
Is AdaptHealth Trading At A Premium To Earnings?
AdaptHealth EV to EBIT ratio is 0.00
Is It Risky To Buy AdaptHealth?
-
How Much Debt Does AdaptHealth Have?
Total long term debt quarterly is $2B -
How Much Cash Does AdaptHealth Have?
Cash and short term investments quarterly total is $100.2M -
What Is AdaptHealth’s Book Value Per Share?
Book value per share is 11.27
Is AdaptHealth Cash Flow Positive?
-
What Is AHCO Cash Flow From Operations?
Cash flow from operations (TTM) is $546.7M -
What Is AdaptHealth’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$188.8M -
What Is AdaptHealth’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$313.8M
AdaptHealth Return On Invested Capital
-
Is Management Doing A Good Job?
AHCO return on invested capital is -5.85% -
What Is AdaptHealth Return On Assets?
ROA measures how assets are converting to revenues and is -4.72% -
What Is AHCO Return On Equity?
ROE is a measure of profitability and is -13.93%
AdaptHealth Earnings Date & Stock Price
-
What Is AdaptHealth's Stock Price Today?
A single share of AHCO can be purchased today for 9.54 -
What Is AdaptHealth’s Stock Symbol?
AdaptHealth trades on the nasdaq under the ticker symbol: AHCO -
When Is AdaptHealth’s Next Earnings Date?
The next quarterly earnings date for AdaptHealth is scheduled on February 27, 2025 -
When Is AHCO's next ex-dividend date?
AdaptHealth's next ex-dividend date is December 12, 2024 -
How To Buy AdaptHealth Stock?
You can buy AdaptHealth shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
AdaptHealth Competitors
-
Who Are AdaptHealth's Competitors?
Below is a list of companies who compete with AdaptHealth or are related in some way:
AdaptHealth Dividend Yield
-
What Is AHCO Dividend Yield?
AdaptHealth’s dividend yield currently is 0% -
What Is AdaptHealth’s Payout Ratio?
AdaptHealth’s payout ratio is 0% -
When Did AdaptHealth Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is AdaptHealth’s Dividend Per Share?
AdaptHealth pays a dividend of $0.00 per share
AdaptHealth Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 21.94% |
Revenue: | 2.38% | -0.43% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 11.39 |
Upside from Last Price: | 19.38% |